Symbol="ARAV"
AssetType="Common Stock"
Name="Aravive Inc"
Description="Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases. The company is headquartered in Houston, Texas."
CIK="1513818"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="LYONDELLBASELL TOWER, 1221 MCKINNEY STREET, SUITE 3200, HOUSTON, TX, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="12866100"
EBITDA="-66033000"
PERatio="None"
PEGRatio="None"
BookValue="-0.331"
DividendPerShare="0"
DividendYield="0"
EPS="-1.15"
RevenuePerShareTTM="0.15"
ProfitMargin="0"
OperatingMarginTTM="-7.28"
ReturnOnAssetsTTM="-1.025"
ReturnOnEquityTTM="-14.97"
RevenueTTM="9194000"
GrossProfitTTM="-57801000"
DilutedEPSTTM="-1.15"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.211"
AnalystTargetPrice="0.25"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="11.41"
PriceToBookRatio="7.28"
EVToRevenue="9.97"
EVToEBITDA="-1.353"
Beta="2.277"
num_52WeekHigh="2.46"
num_52WeekLow="0.11"
num_50DayMovingAverage="0.951"
num_200DayMovingAverage="1.51"
SharesOutstanding="59869000"
DividendDate="2018-10-16"
ExDividendDate="None"
symbol="ARAV"
open="0.16"
high="0.16"
low="0.14"
price="0.15"
volume="13984813.00"
latest_trading_day="2023-08-31"
previous_close="0.17"
change="-0.03"
change_percent="-14.8085%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="90"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="10"
Volume_recent_avg="3672817"
Change_recent_avg="-0.02"
Delta_recent_avg="0.11"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-2.33"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="10"
Aroon_momentum_negative="90"
image_negative_thumbnail_id_1="1123"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0156.jpeg"
image_negative_thumbnail_id_2="495"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0110.jpeg"
image_neutral_thumbnail_id_1="569"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0030.jpeg"
image_neutral_thumbnail_id_2="589"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0010.jpeg"
image_positive_thumbnail_id_1="668"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0040.jpeg"
image_positive_thumbnail_id_2="691"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0017.jpeg"
image_professor_thumbnail_id_1="1193"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
image_professor_thumbnail_id_2="1183"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
